Global Therapeutic Nuclear Medicines Competitive Landscape Professional Research Report 2024

Research Summary

Therapeutic nuclear medicine involves the use of radioactive substances, known as radiopharmaceuticals, for the treatment of various medical conditions. Unlike diagnostic nuclear medicine, which focuses on imaging techniques to visualize internal structures and functions, therapeutic nuclear medicine employs radioactive materials to deliver targeted doses of radiation to specific tissues or organs to treat diseases. Common applications of therapeutic nuclear medicine include the treatment of certain types of cancer, such as thyroid cancer, lymphoma, and bone metastases, as well as non-cancerous conditions like hyperthyroidism and certain types of arthritis. Radiopharmaceuticals used in therapeutic nuclear medicine emit radiation that can selectively destroy or inhibit the growth of abnormal cells while minimizing damage to surrounding healthy tissues. This approach allows for precise and localized treatment, often with fewer side effects compared to traditional therapies. Therapeutic nuclear medicine plays a significant role in modern medicine, offering effective treatment options for a wide range of conditions.

According to DIResearch's in-depth investigation and research, the global Therapeutic Nuclear Medicines market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Therapeutic Nuclear Medicines include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus, Acrotech Biopharma., Progenics Pharmaceuticals, International Isotopes etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Therapeutic Nuclear Medicines. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Therapeutic Nuclear Medicines market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Therapeutic Nuclear Medicines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Therapeutic Nuclear Medicines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Therapeutic Nuclear Medicines Include:

Novartis AG

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Dongcheng

Lantheus

Acrotech Biopharma.

Progenics Pharmaceuticals

International Isotopes

Therapeutic Nuclear Medicines Product Segment Include:

Radium-223

Lutetium-177

Iodine-131

Other

Therapeutic Nuclear Medicines Product Application Include:

Thyroid

Bone Metastasis

Lymphoma

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Therapeutic Nuclear Medicines Industry PESTEL Analysis

Chapter 3: Global Therapeutic Nuclear Medicines Industry Porter's Five Forces Analysis

Chapter 4: Global Therapeutic Nuclear Medicines Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Therapeutic Nuclear Medicines Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Therapeutic Nuclear Medicines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Therapeutic Nuclear Medicines Market Overview

1.1 Product Definition and Statistical Scope

1.2 Therapeutic Nuclear Medicines Product by Type

1.2.1 Global Therapeutic Nuclear Medicines Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Radium-223

1.2.3 Lutetium-177

1.2.4 Iodine-131

1.2.5 Other

1.3 Therapeutic Nuclear Medicines Product by Application

1.3.1 Global Therapeutic Nuclear Medicines Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Other

1.4 Global Therapeutic Nuclear Medicines Market Revenue and Sales Analysis

1.4.1 Global Therapeutic Nuclear Medicines Market Size Analysis (2019-2030)

1.4.2 Global Therapeutic Nuclear Medicines Market Sales Analysis (2019-2030)

1.4.3 Global Therapeutic Nuclear Medicines Market Sales Price Trend Analysis (2019-2030)

1.5 Therapeutic Nuclear Medicines Market Development Status and Trends

1.5.1 Therapeutic Nuclear Medicines Industry Development Status Analysis

1.5.2 Therapeutic Nuclear Medicines Industry Development Trends Analysis

2 Therapeutic Nuclear Medicines Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Therapeutic Nuclear Medicines Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Therapeutic Nuclear Medicines Market Analysis by Regions

4.1 Therapeutic Nuclear Medicines Overall Market: 2023 VS 2024 VS 2030

4.2 Global Therapeutic Nuclear Medicines Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Therapeutic Nuclear Medicines Revenue and Market Share by Region (2019-2024)

4.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Region (2025-2030)

4.3 Global Therapeutic Nuclear Medicines Sales and Forecast Analysis (2019-2030)

4.3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Region (2019-2024)

4.3.2 Global Therapeutic Nuclear Medicines Sales Forecast by Region (2025-2030)

4.4 Global Therapeutic Nuclear Medicines Sales Price Trend Analysis (2019-2030)

5 Global Therapeutic Nuclear Medicines Market Size by Type and Application

5.1 Global Therapeutic Nuclear Medicines Market Size by Type

5.1.1 Global Therapeutic Nuclear Medicines Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Therapeutic Nuclear Medicines Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Therapeutic Nuclear Medicines Market Size by Application

5.2.1 Global Therapeutic Nuclear Medicines Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Therapeutic Nuclear Medicines Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Therapeutic Nuclear Medicines Market Size by Type

6.3.1 North America Therapeutic Nuclear Medicines Sales by Type (2019-2030)

6.3.2 North America Therapeutic Nuclear Medicines Revenue by Type (2019-2030)

6.4 North America Therapeutic Nuclear Medicines Market Size by Application

6.4.1 North America Therapeutic Nuclear Medicines Sales by Application (2019-2030)

6.4.2 North America Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

6.5 North America Therapeutic Nuclear Medicines Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Therapeutic Nuclear Medicines Market Size by Type

7.3.1 Europe Therapeutic Nuclear Medicines Sales by Type (2019-2030)

7.3.2 Europe Therapeutic Nuclear Medicines Revenue by Type (2019-2030)

7.4 Europe Therapeutic Nuclear Medicines Market Size by Application

7.4.1 Europe Therapeutic Nuclear Medicines Sales by Application (2019-2030)

7.4.2 ? Europe Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

7.5 Europe Therapeutic Nuclear Medicines Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Therapeutic Nuclear Medicines Market Size by Type

8.3.1 China Therapeutic Nuclear Medicines Sales by Type (2019-2030)

8.3.2 China Therapeutic Nuclear Medicines Revenue by Type (2019-2030)

8.4 China Therapeutic Nuclear Medicines Market Size by Application

8.4.1 China Therapeutic Nuclear Medicines Sales by Application (2019-2030)

8.4.2 China Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Therapeutic Nuclear Medicines Market Size by Type

9.3.1 APAC (excl. China) Therapeutic Nuclear Medicines Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Therapeutic Nuclear Medicines Revenue by Type (2019-2030)

9.4 APAC (excl. China) Therapeutic Nuclear Medicines Market Size by Application

9.4.1 APAC (excl. China) Therapeutic Nuclear Medicines Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

9.5 APAC (excl. China) Therapeutic Nuclear Medicines Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Therapeutic Nuclear Medicines Market Size by Type

10.3.1 Latin America Therapeutic Nuclear Medicines Sales by Type (2019-2030)

10.3.2 Latin America Therapeutic Nuclear Medicines Revenue by Type (2019-2030)

10.4 Latin America Therapeutic Nuclear Medicines Market Size by Application

10.4.1 Latin America Therapeutic Nuclear Medicines Sales by Application (2019-2030)

10.4.2 Latin America Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

10.5 Latin America Therapeutic Nuclear Medicines Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Therapeutic Nuclear Medicines Market Size by Type

11.3.1 Middle East & Africa Therapeutic Nuclear Medicines Sales by Type (2019-2030)

11.3.2 Middle East & Africa Therapeutic Nuclear Medicines Revenue by Type (2019-2030)

11.4 Middle East & Africa Therapeutic Nuclear Medicines Market Size by Application

11.4.1 Middle East & Africa Therapeutic Nuclear Medicines Sales by Application (2019-2030)

11.4.2 Middle East & Africa Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

11.5 Middle East & Africa Therapeutic Nuclear Medicines Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Therapeutic Nuclear Medicines Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Therapeutic Nuclear Medicines Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Therapeutic Nuclear Medicines Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Therapeutic Nuclear Medicines Average Sales Price by Manufacturers (2020-2024)

12.2 Therapeutic Nuclear Medicines Competitive Landscape Analysis and Market Dynamic

12.2.1 Therapeutic Nuclear Medicines Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Novartis AG

13.1.1 Novartis AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Novartis AG Therapeutic Nuclear Medicines Product Portfolio

13.1.3 Novartis AG Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Bayer

13.2.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Bayer Therapeutic Nuclear Medicines Product Portfolio

13.2.3 Bayer Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 China Isotope & Radiation

13.3.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio

13.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Q BioMed

13.4.1 Q BioMed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Q BioMed Therapeutic Nuclear Medicines Product Portfolio

13.4.3 Q BioMed Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Curium Pharmaceuticals

13.5.1 Curium Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio

13.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Jubilant DraxImage

13.6.1 Jubilant DraxImage Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio

13.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Dongcheng

13.7.1 Dongcheng Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Dongcheng Therapeutic Nuclear Medicines Product Portfolio

13.7.3 Dongcheng Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Lantheus

13.8.1 Lantheus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Lantheus Therapeutic Nuclear Medicines Product Portfolio

13.8.3 Lantheus Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Acrotech Biopharma.

13.9.1 Acrotech Biopharma. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio

13.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.10 Progenics Pharmaceuticals

13.10.1 Progenics Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio

13.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.11 International Isotopes

13.11.1 International Isotopes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 International Isotopes Therapeutic Nuclear Medicines Product Portfolio

13.11.3 International Isotopes Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Therapeutic Nuclear Medicines Industry Chain Analysis

14.2 Therapeutic Nuclear Medicines Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Therapeutic Nuclear Medicines Typical Downstream Customers

14.4 Therapeutic Nuclear Medicines Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support